NRAS and intrahepatic cholangiocarcinoma: In a recent study [24], we found that anti-Notch2 treatment can reduce both HCC and ICC tumor load induced by AKT and neuroblastoma RAS viral oncogene homolog (NRas) oncoproteins, whereas Notch1 suppression decrease HCC and augments ICC occurrence.